The Forefront of Women’s Cardiology: Honoring Dr. Nanette Kass Wenger | WomenHeart

The Forefront of Women’s Cardiology: Honoring Dr. Nanette Kass Wenger

As WomenHeart has evolved over the last 20 years, one person has been a critical pillar for the organization every step of the way. At the 2019 Wenger Awards, Dr. Nanette Kass Wenger was recognized with the 20th Anniversary Legacy Award for her incredible contributions to women’s heart disease research and the WomenHeart organization.

A trailblazing cardiologist, Dr. Wenger was among the first physician-scientists to focus on heart disease in women. She was one of the first women to graduate from Harvard Medical School and has since spent 50 years researching gender differences in heart disease treatment and advocating for female inclusion in heart research.

Dr. Wenger is a pioneer in women’s heart health; she has been an integral part of WomenHeart since its inception. The 20th Anniversary Legacy Award honors her decades of work ensuring women receive the care they deserve.

“WomenHeart’s Board, Scientific Advisory Council, staff and WomenHeart Champions are proud to work with her as we lead the charge in improving women’s heart health,” said WomenHeart Board Member Sharonne N. Hayes, MD. “We are all indebted to Dr. Wenger for her extraordinary and relentless contributions.”

Dr. Wenger has served on over 500 committees, contributed to more than 1,600 scientific publications and still sees patients at Emory Heart and Vascular Center today. She continues to be a groundbreaker in women’s cardiology, her dedication makes one thing clear – her legacy starts and ends with the heart.

Partnering with Purpose

WomenHeart’s Corporate Advisory Committee (CAC) is comprised of representatives from a prestigious group of corporations…

Read More

WomenHeart’s Response to the COVID-19 Pandemic

Every time I turn on the news about the COVID-19 pandemic, I hear about the…

Read More

WomenHeart Encourages Virtual Support for Women Heart Patients

The global pandemic of the novel coronavirus (COVID-19) is in the U.S. and the number…

Read More